Trial Profile
A Multi-center Phase III Randomized Controlled Trial Comparing Between Adjuvant Chemotherapy and Observation in High Risk Patients With Completely Resected Stage Ib Lung Adenocarcinoma
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Vinorelbine (Primary)
- Indications Adenocarcinoma; Lung cancer
- Focus Therapeutic Use
- 05 Nov 2014 New trial record